Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol. 2021;56:593–619.

PubMed  PubMed Central  Google Scholar 

Khanna R, Sarin SK. Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol. 2014;60:421–41.

PubMed  Google Scholar 

de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022;76:959–74.

PubMed  Google Scholar 

Dietrich CF, Bamber J, Berzigotti A, et al. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version). Ultraschall Med. 2017;38:e16–47.

PubMed  Google Scholar 

Erten N, Saka B, Caliskan YK, et al. Acute renal failure due to leukaemic infiltration in chronic lymphocytic leukemia: case report. Int J Clin Pract Suppl. 2005;147:53–5.

Google Scholar 

Yoshida H, Shimizu T, Yoshioka M, et al. The role of the spleen in portal hypertension. J Nippon Med Sch. 2023;90:20–5.

PubMed  Google Scholar 

Manenti A, Forghieri F, Colasanto D, Luppi M. Splenomegaly in hematological malignancies and portal hypertension. Presse Med. 2014;43:1295–6.

PubMed  Google Scholar 

Kimchy AV, Davis WD, Murphy ME, et al. Chronic lymphocytic leukemia involving the liver without high-grade transformation. Ann of Intern Med Clin Cases. 2022;1: e220409.

Google Scholar 

Gan X, Yu S, Zhu M, et al. Case report: Primary myelofibrosis presenting with portal hypertension mimicking cirrhosis. Front Med. 2024;11:1375571.

Google Scholar 

Smalberg JH, Arends LR, Valla DC, et al. Myeloproliferative neoplasms in budd-chiari syndrome and portal vein thrombosis: a meta-analysis. Blood. 2012;120:4921–8.

CAS  PubMed  Google Scholar 

Gioia S, De Santis E, Cerbelli B, et al. Small hepatic veins budd-chiari syndrome and paroxysmal nocturnal hemoglobinuria -The association of two rare entities: a case report. Pathologica. 2020;112:102–4.

PubMed  PubMed Central  Google Scholar 

Gemnani RR Jr, Parepalli A, Kumar S, et al. Chronic myeloid leukemia presenting as non-cirrhotic portal hypertension. Cureus. 2023;15: e40692.

PubMed  PubMed Central  Google Scholar 

Yoshida H, Mamada Y, Taniai N, Tajiri T. Partial splenic embolization. Hepatol Res. 2008;38:225–33.

PubMed  Google Scholar 

Pavel V, Scharf G, Mester P, et al. Partial splenic embolization as a rescue and emergency treatment for portal hypertension and gastroesophageal variceal hemorrhage. BMC Gastroenterol. 2023;23:180.

CAS  PubMed  PubMed Central  Google Scholar 

Ishikawa T, Sasaki R, Nishimura T, et al. Splenic non-infarction volume determines a clinically significant hepatic venous pressure gradient response to partial splenic embolization in patients with cirrhosis and hypersplenism. J Gastroenterol. 2021;56:382–94.

PubMed  Google Scholar 

Wilputte JY, Martinet JP, Nguyen P, et al. Chronic lymphocytic leukemia with portal hypertension and without liver involvement: a case report underlining the roles of increased spleno-portal blood flow and “protective” sinusoidal vasoconstriction. Acta Gastroenterol Belg. 2003;66:303–6.

CAS  PubMed  Google Scholar 

Cai M, Huang W, Lin C, et al. Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications. Eur Radiol. 2016;26:370–80.

PubMed  Google Scholar 

Zhu K, Meng X, Qian J, et al. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients. Dig Liver Dis. 2009;41:411–6.

CAS  PubMed  Google Scholar